Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
04/28/2015 04/29/2015 04/30/2015 05/01/2015 05/04/2015 Date
64.54(c) 64.29(c) 63.73(c) 64.66(c) 65.32(c) Last
8 777 428 4 987 083 6 815 183 4 422 552 4 641 687 Volume
-0.95% -0.39% -0.87% +1.46% +1.02% Change
More quotes
Financials ($)
Sales 2015 15 352 M
EBIT 2015 3 238 M
Net income 2015 2 737 M
Finance 2015 2 214 M
Yield 2015 2,30%
Sales 2016 16 735 M
EBIT 2016 4 286 M
Net income 2016 3 720 M
Finance 2016 2 780 M
Yield 2016 2,43%
PER 2015 37,64
PER 2016 27,85
EV / Sales 2015 6,88x
EV / Sales 2016 6,27x
Capitalization 107 787 M
More Financials
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
05/05 | 10:00amShareholder meeting
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
03:39p BRISTOL MYERS SQUIBB : to Present at Bank of America Merrill Lynch 2015 Health C..
01:49a BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration OKs Supplemental Biolog..
04/30 BRISTOL MYERS SQUIBB : Reports on Pivotal Phase III Opdivo (nivolumab) Lung Canc..
04/29 BRISTOL MYERS SQUIBB : Prices €1.15 Billion of Senior Notes
04/29 BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts Supplemental Bi..
04/29 VANDA PHARMACEUTICALS : Announces the Appointment of Chief Commercial Officer
04/29 BRISTOL MYERS SQUIBB : Trademark Application for "SECURISER LE FUTUR" Filed
04/29 BRISTOL MYERS SQUIBB : Findings on Oligopeptides Reported by Investigators at Br..
More news
Sector news : Pharmaceuticals - NEC
08:41p NOVO NORDISK A/S : Diabetic cycling team ready for Amgen Tour of California
05:13pDJGeneric Drugs Grab Growing Market Share in Mexico--Update
05:11pDJGeneric Drugs Grab Market Share in Mexico
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/01 SEEKING ALPHA'S BIOTECH WEEKLY : A Gilead Victory, Celladon Crumbles, And More
05/01 Breo's Watershed Moment Unlikely To Rescue Glaxo
04/30 Getting The Buy List Ready With Technology, Banks And Oil The Focus
04/29 Bristol-Myers prices ?1.15B debt offering
04/29 FDA accepts sNDA for Opdivo as first line therapy in melanoma


Comments 
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF